Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

Delayed Data
As of Dec 08
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index- which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq- Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures- options and swap contracts- cash and cash equivalents. It is non-diversified.

No recent news for iShares Nasdaq Biotechnology ETF.


1 month+1.94% 3 years+0.73%
3 months-4.50% 5 years+18.57%
1 year+19.06% Since inception+7.28%
Data through 12/09/2017

Quote Details

Previous close$106.07
Open day’s range104.56 – 106.53
Net asset value (NAV)106.28 (12/08/2017)
Daily volume2,811,527
Average volume (3 months)2,766,663
Data as of 4:00pm ET, 12/08/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+18.57%+16.79%
Expense Gross exp ratio0.47%1.33%
Risk 5 year sharpe ratio0.841.12
Net assets$9.8B$3.1B
Average market cap$16.7B$27.3B
Average P/E20.422.4
Dividend / Share--0.30%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BIIB Biogen8.67%
AMGN Amgen8.41%
GILD Gilead Sciences7.61%
CELG Celgene6.18%
REGN Regeneron Pharmaceuticals5.65%
ILMN Illumina Inc4.79%
VRTX Vertex Pharmaceuticals Inc3.83%
ALXN Alexion Pharmaceuticals Inc3.28%
INCY Incyte Corp3.07%
MYL Mylan NV3.06%